Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Most rapid mechanism showing effects within days for acute injuries though chronic repair takes longer
A 2017 study by Hsieh and colleagues in Journal of Molecular Medicine reported that BPC-157, in chick chorioallantoic membrane, rat hind-limb ischemia, and HUVEC models, directionally increased vessel density, accelerated blood-flow recovery in ischemic muscle, and time-dependently activated the VEGFR2-Akt-eNOS signaling pathway via VEGFR2 internalization a mechanistic preclinical finding for which numeric effect sizes are not reported in the abstract
These statements have not been evaluated by the FDA.
Alternating AM/PM is safest for those using high-concentration LAA
Some preclinical work suggests synergy with BPC-157: TB-500 for systemic cell migration/angiogenesis, BPC-157 for local anti-inflammatory repair leading to better tendon-to-bone integration or muscle recovery in animal studies
For more information, contact us or schedule an appointment online
